Riestra, Sabino; Márquez, Lucía; Domènech, Eugeni; The Eneida Registry Of Geteccu
(MDPI, 2022)
Aims: patients receiving antitumor necrosis factor (anti-TNF) therapy are at risk of developing tuberculosis (TB), usually due to the reactivation of a latent TB infection (LTBI). LTBI screening and treatment decreases the ...